Search research articles
Contact Us
Filters
Showing results (201-210 of 249) with videos related to
Page
of 25
Sort By:
The European Respiratory Journal
|
October 28, 2024
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD
R Chad Wade, Fernando J Martinez, Gerard J Criner, et al.
Respiratory Research
|
November 1, 2019
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial
François Maltais, Leif Bjermer, Edward M Kerwin, et al.
NPJ Primary Care Respiratory Medicine
|
May 26, 2021
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
Sandeep Bansal, Martin Anderson, Antonio Anzueto, et al.
Critical Care Medicine
|
June 24, 2015
A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
Jason D Christie, Steven Vaslef, Philip K Chang, et al.
Thorax
|
January 31, 2012
Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI
Helen Marshall, Martin H Deppe, Juan Parra-Robles, et al.
Respiratory Research
|
May 31, 2020
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
Gary T Ferguson, Nicola Brown, Chris Compton, et al.
The American Journal of Gastroenterology
|
November 1, 1996
GI complications after orthotopic lung transplantation
E I Lubetkin, D A Lipson, H I Palevsky, et al.
Journal of the American Heart Association
|
September 14, 2022
Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial
Mark T Dransfield, Gerard J Criner, David M G Halpin, et al.
Respirology (Carlton, Vic.)
|
August 15, 2022
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial
Philip J Thompson, Gerard J Criner, Mark T Dransfield, et al.
The European Respiratory Journal
|
April 18, 2020
The effect of exacerbation history on outcomes in the IMPACT trial
David M G Halpin, Mark T Dransfield, MeiLan K Han, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 249) with videos related to
Sort By:
Page
of 25
The European Respiratory Journal
|
October 28, 2024
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD
R Chad Wade, Fernando J Martinez, Gerard J Criner, et al.
Respiratory Research
|
November 1, 2019
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial
François Maltais, Leif Bjermer, Edward M Kerwin, et al.
NPJ Primary Care Respiratory Medicine
|
May 26, 2021
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
Sandeep Bansal, Martin Anderson, Antonio Anzueto, et al.
Critical Care Medicine
|
June 24, 2015
A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
Jason D Christie, Steven Vaslef, Philip K Chang, et al.
Thorax
|
January 31, 2012
Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI
Helen Marshall, Martin H Deppe, Juan Parra-Robles, et al.
Respiratory Research
|
May 31, 2020
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
Gary T Ferguson, Nicola Brown, Chris Compton, et al.
The American Journal of Gastroenterology
|
November 1, 1996
GI complications after orthotopic lung transplantation
E I Lubetkin, D A Lipson, H I Palevsky, et al.
Journal of the American Heart Association
|
September 14, 2022
Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial
Mark T Dransfield, Gerard J Criner, David M G Halpin, et al.
Respirology (Carlton, Vic.)
|
August 15, 2022
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial
Philip J Thompson, Gerard J Criner, Mark T Dransfield, et al.
The European Respiratory Journal
|
April 18, 2020
The effect of exacerbation history on outcomes in the IMPACT trial
David M G Halpin, Mark T Dransfield, MeiLan K Han, et al.
Page
of 25